A Phase 1 clinical study for patients with Advanced Cancer/Advanced Malignancies
A clinical research study of Bendamustine, Obinutuzumab, Polatuzumab Vedotin and Rituximab for the treatment of Lymphoma, Lymphoma B-Cell, Non-Hodgkin's or Follicular Lymphoma
Horizon Oncology Center
A clinical trial seeking patients for a research study for the treatment of B-Cell Lymphoma
Horizon Oncology Research, Inc.
A clinical trial to evaluate treatments using LAM-002A for patients with Lymphoma, Non-Hodgkin